Cargando…
Malignant Melanoma in a Retrospective Cohort of Immunocompromised Patients: A Statistical and Pathologic Analysis
SIMPLE SUMMARY: Despite recent advances in immunotherapy, melanoma remains the deadliest cutaneous malignancy. Immunocompromised patients are at heightened risk of developing melanoma and experience greater levels of morbidity and mortality compared to their non-immunocompromised peers with the dise...
Autores principales: | Killeen, Trevor F., Shanley, Ryan, Ramesh, Vidhyalakshmi, Giubellino, Alessio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377403/ https://www.ncbi.nlm.nih.gov/pubmed/37509262 http://dx.doi.org/10.3390/cancers15143600 |
Ejemplares similares
-
Correlation of MET and PD-L1 Expression in Malignant Melanoma
por: Song, Kyu Young, et al.
Publicado: (2020) -
The Current State of Treatment and Future Directions in Cutaneous Malignant Melanoma
por: Ernst, Madison, et al.
Publicado: (2022) -
Imaging tests in cutaneous malignant melanoma staging: a retrospective cohort()()
por: Souza, Luiza Boava, et al.
Publicado: (2020) -
Neoehrlichia mikurensis in Danish immunocompromised patients: a retrospective cohort study
por: Gynthersen, Rosa Maja Møhring, et al.
Publicado: (2023) -
Expression and Prognostic Evaluation of the Receptor Tyrosine Kinase MET in Canine Malignant Melanoma
por: Koo, Karen, et al.
Publicado: (2023)